Ernexa Therapeutics ERNA
NASDAQ ERNA
$2.08 -0.03 (-1.66%)
As of: Oct 22, 2026 · 3:59 PM EDT

Ernexa Therapeutics (ERNA) Goodwill impairment charges (2020 - 2026)

Updated

Ernexa Therapeutics (ERNA) posted Goodwill impairment charges of $2.04 million for Q1 2026.

Analysis

Ernexa Therapeutics (ERNA) Goodwill impairment charges (2020 - 2026) Analysis & Trends

For FY2020, Ernexa Therapeutics' Goodwill impairment charges came in at $662,000.

  • In prior years, Ernexa Therapeutics' Goodwill impairment charges was $261,000 in FY2018.
  • The Q1 2026 figure stands as the lowest quarterly Goodwill impairment charges since Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Ernexa Therapeutics 2.45 Mn -16.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.04 Mn
Mar 31, 2020 662,000.00
API Access

Ernexa Therapeutics Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=ERNA&period=max&api_key=YOUR_API_KEY